The importance of the Edmonton Obesity Staging System in predicting postoperative outcome and 30-day mortality after metabolic surgery

Chiappetta, Sonja; Stier, Christine; Squillante, Simone; Theodoridou, Sophia; Weiner, Rudolf A.

doi:10.1016/j.soard.2016.02.042

Cited by 40 publications

(24 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The questionnaires were completed 1 day before surgery (T0) and at 6 (T6) and 24 (T24) months of follow-up (FU). The patients' data were obtained from the medical report and included sex, age, height (cm), weight (kg), BMI (weight per height squared), Edmonton Obesity Staging System (EOSS) classification [12], and excess weight loss and total body weight loss (both expressed as a percentage).…”

Section: Methodsmentioning

confidence: 99%

“…All surgeries were performed at our institution, a high-volume certified center of excellence for obesity and metabolic surgery accredited by the European Accreditation Council for Bariatric Surgery. The surgical techniques for SG, RYGB, and OAGB have been described elsewhere [12]. The primary outcome measure was the change in addiction (addiction remission) regarding food.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Remission of Food Addiction Does Not Induce Cross-Addiction after Sleeve Gastrectomy and Gastric Bypass: A Prospective Cohort Study

et al. 2020

Self Cite

View full text Add to dashboard Cite

Background: The hypothesis of "cross-addiction" has never been validated, and numerous aspects speak against it. Objectives: To compare the differences between sleeve gastrectomy (SG) and gastric bypass (GB) procedures concerning cross-addiction. Setting: Center for maximum care in Germany. Methods: We performed a prospective analysis of patients undergoing SG or GB as the first surgical treatment for severe obesity. All patients completed validated questionnaires to evaluate food intake (Yale Food Addiction Scale, YFAS), alcohol intake (Alcohol Use Disorders Identification Test), nicotine use (Fagerstrom Test for Nicotine Dependence), exercise (Exercise Addiction Inventory), drug addiction (20-item Drug Abuse Screening Test), and Internet use disorder (Internet Addiction Test) before the operation (T0) and 6 (T6) and 24 (T24) months postoperatively (ClinicalTrials.gov identifier: NCT02757716). Results: One hundred thirteen patients underwent SG (n = 68) or GB (n = 45). At the follow-up, 61% completed the questionnaires at T6 and 44% at T24. In the YFAS, the percentage of patients diagnosed with food addiction decreased from 69 to 10%, and the mean symptom count decreased from 3.52 ± 1.95 to 1.26 ± 0.99 at T24 (p < 0.0001); these values did not differ between the surgical groups (p = 0.784). No significant evidence of cross-addiction was observed for

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Remission of Food Addiction Does Not Induce Cross-Addiction after Sleeve Gastrectomy and Gastric Bypass: A Prospective Cohort Study

et al. 2020

Self Cite

View full text Add to dashboard Cite

show abstract

“…It may be important to also note that BMI may not be the best indicator of obesity related morbidity or mortality. Thus, for example, risk stratification based on the EOSS [17], which classifies obesity in five stages based on the presence of medical, mental, and/or functional complications rather than on BMI has been shown to be a better predictor of all-cause mortality in patients with obesity [18] and adverse outcomes in patients undergoing bariatric surgery [19]. It may well be that EOSS stages may better describe the risk associated with COVID-19 infections in patients with obesity than BMI alone.…”

mentioning

confidence: 99%

COVID-19 and the role of chronic inflammation in patients with obesity

Chiappetta¹,

Sharma

Bottino³

et al. 2020

Int J Obes

Self Cite

213

166

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) and the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a particular risk to people living with preexisting conditions that impair immune response or amplify pro-inflammatory response. Low-grade chronic systemic inflammation, common in people with obesity, is associated with the development of atherosclerosis, type 2 diabetes, and hypertension, well known comorbidities that adversely affect the outcomes of patients with COVID-19. Risk stratification based on the Edmonton Obesity Staging System (EOSS), which classifies obesity based on the presence of medical, mental, and/or functional complications rather than on body mass index (BMI), has been shown to be a better predictor of all-cause mortality and it may well be that EOSS stages may better describe the risk of hyperinflammation in patients with COVID-19 infection. Analyzing a group of metabolic ill patients with obesity (EOSS 2 and 3), we found an increased interleukin-6 and linear regression analysis showed a positive correlation with C-reactive protein (CRP) (p = 0.014) and waist-to-hip-ratio (WHR) (p = 0.031). Physicians should be aware of these findings in patients with COVID-19 infection. Early identification of possible hyperinflammation could be fundamental and should guide decision making regarding hospitalization, early respiratory support, and therapy with immunosuppression to improve mortality.

show abstract

“…The surgical techniques for LSG, LRYGB, and LOAGB have been described before [15]. Postoperative data collection and documentation were standardized in all patients and routine discharge was on postoperative day (POD) 5, which is the routine discharge in our center.…”

Section: Methodsmentioning

confidence: 99%

The role of C-reactive protein after surgery for obesity and metabolic disorders

Chiappetta

Jamadar

Stier

et al. 2020

Surgery for Obesity and Related Diseases

Self Cite

View full text Add to dashboard Cite

The importance of the Edmonton Obesity Staging System in predicting postoperative outcome and 30-day mortality after metabolic surgery

Cited by 40 publications

References 24 publications

Remission of Food Addiction Does Not Induce Cross-Addiction after Sleeve Gastrectomy and Gastric Bypass: A Prospective Cohort Study

Remission of Food Addiction Does Not Induce Cross-Addiction after Sleeve Gastrectomy and Gastric Bypass: A Prospective Cohort Study

COVID-19 and the role of chronic inflammation in patients with obesity

The role of C-reactive protein after surgery for obesity and metabolic disorders

Contact Info

Product

Resources

About